So the last two weeks of my biology life have been devoted to writing (and procrastinating) this bear of a paper. Here's the link, but unless you want to read 6 pages of boring, let me give you the basic rundown.
https://docs.google.com/document/d/1YfunzCm4eShKU773JDjPrKet2Rav3mqiLbhdSpz2KEw/edit?usp=sharing
So there's this gene that's involved in about a quarter of breast cancer cases, called HER2. It produces this protein, neu, that stimulates cell growth, but when there's too much of it, the cell can go haywire. This extra growth makes the cancer more deadly and painful, so HER2-positive cancer is one of the worst iterations of breast cancer there is. Basically, there's this drug called Trastuzumab that can mark the cells with HER2 overexpression, and inhibit their growth. Other treatments consist of vaccines that build up resistance against the peptides created by HER2, and stop growth from getting out of hand. The downside is that scientists barely understand how HER2 and its peptides work, so developing treatments is difficult.
Well that's all for now! See you!
Hey! This paper is on my website for standards 7 and 8! Check it out here
https://sites.google.com/site/michelleshonorsbio/webb-science-practices-standards/7-engaging-in-argument-from-evidence
https://sites.google.com/site/michelleshonorsbio/webb-science-practices-standards/8-obtaining-evaluating-and-communicating-information
No comments:
Post a Comment